What Nexus Values does

Nexus Values Ltd is a UK-based specialist value strategy consultancy serving the healthcare sector, founded in 2021 and headquartered at Britannia Business Park in Southend on Sea, Essex. The firm is co-owned and co-founded by Ebony Samuels (former VP of Value Strategy at Parexel) and Michael Tang (former interim head of US Pricing & Market Access at Parexel), whose combined 30+ years of health economics, outcomes research, and market access experience form the core of the offering.

The company organizes its service portfolio around three pillars — Identifying Value (landscape assessments, competitor mapping, literature reviews, internal workshops), Framing Value (value proposition development, evidence generation planning, payer objection handling), and Communicating Value (Global and Local Value Dossiers, AMCP dossiers, Early HTA Scientific Advice, payer communication tools) — supplemented by Training, Team Development, and Resource Support services. There is no proprietary technology platform; the product is expert-led human advisory delivered by senior consultants rather than the junior-staff pyramid typical of large consultancies.

Nexus Values generates revenue through project-based professional services engagements priced on bespoke terms (not publicly disclosed), sold via direct consultative enterprise sales to biotech firms, mid-to-large pharmaceutical companies, medical device developers, and other market access consultancies. The firm has not raised external funding and remains a privately held, founder-led entity with no disclosed headcount, revenue, or institutional investors.

Name

Nexus Values

Legal name

Nexus Values Ltd

Website

https://nexusvalues.com

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

11–50 employees

Short description

Nexus Values is a UK-based specialist healthcare value strategy consultancy founded in 2021 by ex-Parexel executives, offering senior expert-led advisory across identifying, framing, and communicating product value to biotech, mid-to-large pharma, medical device developers, and consultancies.

Ownership category

akta.pro rank

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Consultancy Services: The company generates revenue through providing expert-led consultancy services focused on value strategy across the product lifecycle. Services include identifying value, framing value, and communicating value for pharmaceutical and healthcare products. Revenue appears to be project-based consulting engagements with no disclosed specific pricing model.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Nexus Values is a specialist value strategy consultancy that partners with biotech, mid-to-large pharmaceutical, and medical device clients to identify, frame, and communicate the value of their products across the lifecycle. Engagements span landscape assessments, literature reviews, value proposition and key message development, evidence generation planning, payer strategy, Global and Local Value Dossiers, AMCP dossiers, HTA writing support, and related training and team development.

Product overview

Nexus Values is a specialist value strategy consultancy offering expert-led solutions across the healthcare product lifecycle. The company's service portfolio is organized around three core value strategy pillars: Identifying Value (landscape assessments, literature reviews, workshops), Framing Value (value proposition development, gap analysis, evidence generation planning), and Communicating Value (Global/Local Value Dossiers, AMCP dossiers, HTA support). These are delivered alongside consultancy support services including Training, Team Development, and Resource Support. The consultancy works with biotech, mid to large pharma, medical device developers, and consultancies to optimize market access and patient treatment access.

Differentiator

Problem solved

Functional benefit

Products and services

• Identifying Value Services Expert-led solutions for identifying product value, including landscape assessments, competitor mapping, targeted literature reviews, internal value strategy workshops, one-to-one discussions, and value strategy pathway planning and guidance for biotech, pharma, medical device, and consultancy clients.
• Framing Value Services Expert-led solutions for framing product value, including value proposition and key value message development, data gap analysis, internal workshops, evidence generation planning, payer value strategy, and payer objection handling for biotech, pharma, medical device, and consultancy clients.
• Communicating Value Services Expert-led solutions for communicating product value through Global and Local Value Dossiers, AMCP dossiers, Early HTA Scientific Advice and HTA writing support, internal roll-out and training, and payer communication tools and slide decks, for biotech, pharma, medical device, and consultancy clients.
• Training Services Modular training series covering 'Introduction to...' topics, internal team workshops, and support in creating value-driven client materials, delivered to pharma, biotech, medical device, and consultancy clients.
• Team Development Services Comprehensive team development support including set-up (standards and processes development), recruitment (job descriptions, CV screening, assessment, interview), maintenance (skills assessments), and expansion (business planning) for client teams.
• Resource Support Services Flexible resource support for filling project skills gaps, providing leave coverage, and supporting project completion on client engagements.

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• Parexel: Global CRO where both Nexus Values co-founders previously held senior value strategy and market access leadership. Overlaps directly in value dossier, HEOR, and market access services but at vastly larger scale and broader portfolio.
• Charles River Associates (Life Sciences Practice): Global consulting firm with a dedicated life sciences practice offering HEOR, market access, pricing, and value communication services that overlap materially with Nexus Values' value strategy portfolio.
• Evidera (PPD): Dedicated HEOR, market access, and real-world evidence consultancy within PPD/Thermo Fisher. Directly competes on value dossiers, evidence generation planning, and HTA submissions for pharma clients.
• IQVIA: Largest life sciences services and data provider, with a substantial HEOR and market access practice offering value strategy, evidence generation, and HTA support comparable to Nexus Values' offering, alongside much broader commercial and clinical capabilities.

Direct peers

• Market Access Solutions (MAS): Specialist market access consultancy focused on value proposition development, evidence generation, and payer communication for pharma and medical devices, closely aligned with Nexus Values' identifying/framing/communicating value pillars.
• Wickenstones: UK-based specialist market access and pricing consultancy offering value communication, payer engagement, and HTA support to pharma and biotech clients — a similar boutique model targeting the same buyer profile.
• PDCI Market Access: Canadian-based consultancy providing pricing, reimbursement, and HTA submission support to pharma and biotech clients, overlapping with Nexus Values' value dossier and payer strategy services.
• Validare: Specialist value communication consultancy delivering value dossiers, AMCP format dossiers, and payer engagement support to pharma clients — a directly comparable niche value strategy provider.

Emerging players

• AxDev: Specialist consultancy providing evidence generation planning, value communication, and medical affairs support to life sciences clients, with adjacent rather than identical overlap to Nexus Values' market access focus.
• Maverix Health: Emerging life sciences consultancy offering market access, HEOR, and evidence strategy services to pharma and biotech, partially overlapping with Nexus Values' value strategy offering.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/nexus-values

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Nexus Values